Amneal Inaugurates Rs 135 Crore Ahmedabad Office
Amneal Pharmaceuticals has inaugurated a Rs 135 crore office in Ahmedabad, Gujarat, to strengthen its global operations. The opening was reported on 23 October 2026 by both BW Healthcare World and Express Pharma, making it one of the more significant office-level capital commitments by a pharmaceutical company in the city in recent months.
The facility is located in Ahmedabad, which sits within Gujarat — the state that accounts for the largest concentration of drugs and pharmaceuticals projects tracked across India.
| Detail | Information |
|---|---|
| Project | Corporate Office Inauguration |
| Promoter / Company | Amneal Pharmaceuticals |
| Location | Ahmedabad, Gujarat |
| Reported Investment | Rs 135 crore |
| Stated Purpose | Strengthen global operations |
| Reported On | 23 October 2026 |
Gujarat's Dominant Position in India's Pharma Project Pipeline
The Amneal opening reflects the broader concentration of pharmaceutical capital activity in Gujarat. Projects India tracks 1,795 active projects in the drugs and pharmaceuticals sub-sector across India, of which 607 — the highest count of any state — are located in Gujarat. Telangana follows with 244 tracked projects, Andhra Pradesh with 231, Karnataka with 215, Maharashtra with 167, and Himachal Pradesh with 59.
Within Ahmedabad itself, Projects India currently tracks an API and intermediates manufacturing project by Dwirayu Pharma Private Limited, valued at Rs 7.5 crore and at the under-approvals stage, illustrating the range of investment sizes active in the city at the same time as the Amneal announcement.
Stage Breakdown: Where the Pipeline Stands
Across all 1,795 tracked drugs and pharmaceuticals projects in India, the stage breakdown reveals a substantial volume of work that has not yet been awarded. Of tracked projects:
- 638 are under approvals — the earliest stage at which suppliers and equipment makers can position themselves
- 362 have construction started
- 323 are completed
- 138 have approvals received but construction not yet begun
- 138 are on hold
- 98 are at the planning stage
The combined under-approvals and approvals-received count of 776 projects represents a substantial forward order book for contractors, civil engineers, equipment suppliers and fit-out firms operating in this sub-sector. Projects India has added 15 drugs and pharmaceuticals projects to its database in the last 90 days alone.
Recent Project Activity Across the Sub-Sector
The Amneal inauguration coincides with a steady flow of smaller manufacturing investments being tracked nationally. Among recently logged projects: Chromo Laboratories India Private Limited is pursuing a Rs 195 crore bulk drugs and API intermediates expansion at Sangareddy, Telangana, currently under approvals; Centaur Pharmaceuticals Private Limited has started construction on a Rs 42 crore pharmaceutical facility in South Goa; and Aadi Rishabh Chemicals LLP has begun construction on a Rs 10 crore API and API intermediates project in Palghar, Maharashtra.
At the smaller end, Agadi Labs in Bengaluru and Aminosaure Private Limited in Tirunelveli are both at the under-approvals stage for new manufacturing units valued at Rs 11 crore and Rs 8 crore respectively, reflecting the continued entry of smaller promoters into the sector. A full view of active projects is available on the Projects India tracked projects page.
What this means for suppliers and contractors
For suppliers and contractors, the Amneal office inauguration is primarily a signal of the company's continued commitment to India as an operational base. The Rs 135 crore scale indicates meaningful fit-out, infrastructure and services spend, though the precise scope — civil, MEP, IT infrastructure, laboratory fit-out — is not available from published reports.
The broader opportunity, however, lies in the pipeline around it. Gujarat's 607 tracked pharma projects, of which a significant share remain at pre-construction stages, represent an extended forward opportunity for those with established presence in the state. Equipment makers supplying API manufacturing lines, clean-room fit-out contractors, and utilities providers will find the under-approvals cohort — 638 projects nationally — the most actionable segment to monitor for early engagement.
The industrial projects sector overview on Projects India covers the full range of active opportunities across drugs and pharmaceuticals and adjacent sub-sectors. Suppliers tracking similar investments elsewhere in India can also reference recent coverage of comparable projects, including the Rs 81 crore SJS Enterprises pharma facility in Pune.
Frequently asked questions
How much has Amneal Pharmaceuticals invested in its Ahmedabad office?
Amneal Pharmaceuticals has inaugurated an office in Ahmedabad, Gujarat at a reported investment of Rs 135 crore. The purpose stated in published reports is to strengthen the company's global operations. The inauguration was reported on 23 October 2026 by two publications.
How many pharmaceutical projects are tracked in Gujarat?
Projects India tracks 607 drugs and pharmaceuticals projects in Gujarat, the highest count of any Indian state. Nationally, 1,795 projects are tracked in this sub-sector, with 638 currently at the under-approvals stage and 362 with construction already started.
What is the total value of pharma projects tracked in India?
Projects India tracks 1,795 drugs and pharmaceuticals projects across India. Individual project values vary widely, from under Rs 10 crore for small API units to Rs 195 crore for larger expansion projects. Fifteen new projects were added to the database in the last 90 days.
